FUM Share Price Performance
Recent FUM News & Updates
No updates
Futura Medical plc Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.0043
- Gross Margin
- 69.58%
- Net Profit Margin
- 9.28%
- Debt/Equity Ratio
- 0%
Futura Medical plc Competitors
About FUM
- Founded
- 2001
- Employees
- 14
- CEO
- WebsiteView website
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
U.K. Market Performance
- 7 Days: 0.3%
- 3 Months: 8.0%
- 1 Year: 6.7%
- Year to Date: 7.4%
The market has been flat in the last week, however the Healthcare sector is down 3.7%. More promisingly, the market is up 6.7% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue readingLast Week
